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POTENTIATION OF ANTICOAGULANT TOXICITY TO Rattus rattus BY TWO
NON-STEROID ANTI-INFLAMMATORY DRUGS
SHAKUNTHALA SRIDHARA and T. R. KRISHNAMURTHY, AICRP on Rodent Control, College of Basic
Sciences and Humanities, University of Agricultural Sciences, G.K.V.K, Bangalore, 560 065. India
ABSTRACT: In view of resistance reported to have developed towards second generation anticoagulants and the problem of
bait shyness and neophobia when acute rodenticides are used it becomes imperative that methods be evolved to overcome these
problems. Attempts to potentiate anticoagulants for effective rodent control is a new concept with very few studies. Experiments using two non-steroid anti-inflammatory, drugs namely ibuprofen and phenylbutazone at 80 mg/kg and 50 mg/kg body
weight respectively to potentiate the action of two second generation anticoagulants, brodifacoum and bromadiolone yielded
positive results for Rattus rattus. The drugs reduced the lethal dose required for 100% mortality as well as days to death. Field
trials confirmed laboratory findings.
Proc. 15th Vertebrate Pest Conf. (J. E. Borrecco & R. E. Marsh,
Editors) Published at University of Calif., Davis. 1992

INTRODUCTION
The concept of total rodent eradication still remains a
dream with acute rodenticides like zinc phosphide leaving
bait shy populations and anticoagulants resulting in resistant
strains. Even the second generation anticoagulants are reported to have led to development of resistance (Rowe et al.
1981). This new trend makes it invitable to potentiate second
generation anticoagulants to ensure complete mortalities
quickly. Certain drugs are known to interact with oral anticoagulants by a variety of mechanisms such as altered absorption, binding and/or metabolism of protein. The action of
phenylbutazone in potentiating anticoagulant effect is well
known (Lewis et al. 1974). Hence experiments were designed to study the possibility of potentiation of two second generation anticoagulants viz bromadiolone (C30 H23 Br O4),
3-(4 hydroxy-3- coumarinyl), 3 phenyl-l-(4 bromo-p-biphenyl) propanol) also known as ‘Supercaid’ and ‘Maki’ and
brodifacoum (C31 H23 O3 Br), (-(3-(4 bromobiphenyl-4-yl) 1,2,3,4-tetra hydronaphthyl-I-yl)-4-hydroxy coumarin) by
two non-steroidal, anti-inflammatory drugs (NSAIDs)
namely phenylbutazone and ibuprofen.

weeks.
Choice test—Two batches of rats (N=12) were exposed
to wax cakes and non-poisonous ragi bait (Eleusine coracana)
+ 10% groundnut oil (Arachis hypogea) for 24 and 48 hrs respectively. At the end of exposure period, data on the amount
of ragi bait and poison cake consumed, days to death and
mortality were documented.
Oral toxicity studies—After acclimation to laboratory
conditions R. rattus with equal representation of the two sexes
were weighed and caged individually and starved overnight.
Calculated amount of technical grade (99.99%) bromadiolone,
were dissolved in known quantities of polyethylene glycol to
get the required percent concentration. Depending on the
weight of the animal, calculated amounts of bromadiolone
was injected directly into the stomach of 20 animals by oral
intubation in order to get 1, 2, 3, 4 and 5 mg poison/kg body
weight. Six hours later the rats were given standard rat feed
and were maintained for 3 weeks on the same feed during
which time the days to death and mortality were recorded.
Using probit analysis (Litchfield and Wilcoxin 1949), the
LD50 values were calculated.

METHODS
The experimental procedure consisted of five steps: First
to establish toxicity of wax cakes and technical grade concentration of bromadiolone and brodifacoum to Rattus rattus.
Secondly to establish the tolerance limits ofR. rattus to
ibuprofen and phenylbutazone. Third to evaluate the potentiation of wax cakes of brodifacoum and bromadiolone by the
two drugs. Fourth to test the potentiation of technical grade
concentrations of the two rodenticides. Finally field evaluation of wax cakes mixed with the two drugs was carried out.
All experiments were conducted on wild, field caught Rattus
rattus.

Brodifacoum Toxicity
No choice and choice tests were carried out on
brodifacoum wax cakes (0.005%). The procedure followed,
being similar to bromadiolone evaluation.
Acute oral toxicity studies—Five concentrations of technical grade brodifacoum (99.99%) namely 0.5, 1.0, 1.5, 2.0
and 2.5 mg/kg were employed for determining LD50 values.
The experimental details were similar to bromadiolone oral
toxicity tests.

Bromadiolone Toxicity
No choice test—Rats (N = 12) after being acclimated to
laboratory conditions were weighed and caged individually.
Each rat was exposed to a single wax cake (20g) containing
0.005% rodenticide for 24 hrs and its intake recorded. Thereafter the subjects were fed standard rat feed and observed for
poison ingested, days to death and mortality for 3 weeks. A
similar no choice test on 12 subjects was conducted but by
exposing them to the cake for 48 hrs. Data on poison ingested, mortality and days to death were recorded over 3

Tolerance limit for ibuprofen and phenylbutazone
Ibuprofen—Four batches of R. rattus comprising of 10
rats each (5 males and 5 females) were acclimated and starved
overnight prior to the test. To one batch of rats 5ml ibuprofen
(Fenlong, Sol Pharmaceuticals Ltd, Hyderabad) caliberated
to contain 20 mg/kg body weight was directly fed into the
stomach by oral intubation. Similarly the remaining three
groups of rats were given dosages of 40 mg/kg, 80 mg/kg and
100 mg/kg. Twelve hours later experimental rats were fed
normally and were kept under observation for mortality for
three days.
Phenylbutazone—Forty rats divided into four batches of
10 each were subcutaneously injected with calibrated doses
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of 50 mg/kg, 100 mg/kg, 150 mg/kg and 200 mg/kg after
starving them overnight. Twelve hrs after treatment the rats
were put on regular diet for 3 days and mortalities recorded.
Potentiation of wax cakes of bromadiolone and
brodifacoum by ibuprofen and phenylbutazone
Bromadiolone—No choice test—Twenty-four R. rattus
were individually caged and starved overnight. One batch of
12 rats was fed ibuprofen at 80 mg/kg body weight by oral
intubation and the second batch subcutaneously injected with
50 mg/kg phenylbutazone. In the afternoon all the rats were
given one bromadiolone wax cake (20 mg) for 24 hours after
which the rats were fed normally and kept under observation
for mortality.
Choice test — The acclimated rats, numbering 24, were
starved overnight. Next morning they were divided into two
batches: one batch was injected with 50 mg/kg phenylbutazone and the other intubated with 80 mg/kg body weight
with ibuprofen. Both groups were exposed to a choice test of
30g each of mixed cereals and standard rat feed and 20g
bromadiolone wax cake containing 0.005% rodenticide for
24 hrs. Later they were maintained on standard rat feed and
observed for mortality.
Brodifacoum—Evaluation of potentiation of brodifacoum wax cakes (0.005%) was done by carrying out no
choice and choice tests as described for bromadiolone. In all
the tests quantity of wax cake consumed was weighed and converted to g consumed/lOOg body weight for comparisons.
Potentiation of technical grade anticoagulants.
Bromadiolone—A total of 20 R. rattus were acclimated
to laboratory, starved overnight and weighed in the morning.
To one batch, ibuprofen at 80 mg/kg was administered by
stomach intubation and to the second batch of 10 rats
phenylbutazone at 50 mg/kg was injected subcutaneously. In
the afternoon all the 20 animals were administered
bromodiolone dissolved in polyethylene glycol at 2 mg/kg.
After four hours they were fed standard rat feed and observed
for percent mortality and duration to death.

Brodifacoum—To ibuprofen and phenylbutazone
administrated rats as in the previous experiments, 1 mg
brodifacoum/kg was stomach fed by intubation followed by
observations on mortality and days to death.
Field Evaluation of potentiated anticoagulants
Nine poultry sheds measuring 100' x 40' and housing 2,000 chicks each at the Central Poultry Breeding and
Research Institute, at Hesaraghatta, 25 km from Bangalore
were selected for evaluating the potentiated anticoagulant activity of bromadiolone and brodifacoum. The sheds were
infested with only Rattus rattus. The population in each shed
was estimated by surplus baiting method (Barnett et al.1951)
using poultry feed. The rates of bait consumption per shed are
presented in Table 1. Based on earlier observations that a
single R. rattus weighs an average of 11Og and consumes a
mean of 14g poultry feed (Krishnamurthy 1990) the number
of rats present in each shed and their total weights were extrapolated (Table. 1). The tolerable and effective dosages of
ibuprofen and phenylbutazone for the rat population of each
shed was calculated as in Table 1. The evaluation of their
potentiation was carried out in two sets of experiments. In the
first set of tests, wax cakes of brodifacoum and bromadiolone
were powdered and mixed with calculated amounts of
ibuprofen and phenylbutazone separately. Thus shed 1 was
exposed to brodifacoum + ibuprofen, shed 2 to brodifacoum
+ phenylbutazone, shed 3 to bromadiolone + ibuprofen, shed
4 to bromadiolone + phenylbutazone at the dosages presented
in Table 1. Each shed had 10 bait points. Similarly sheds 5 to
8 were exposed to 10 bait stations of poultry containing the
two drugs as calibrated in Table 1. In sheds 5 and 6
brodifacoum cake was placed beside each bait container and
in sheds 7 and 8 bromadiolone cakes were placed similarly.
The 9th shed served as control. After 48 hrs of exposure the
baits were removed and population estimates carried out by
surplus baiting. The difference in the bait consumed prior to
and after treatment were converted into percent reduction in
bait consumed and tabulated (Table 2). The significance of
potentiation of bromadiolone and brodifacoum by ibuprofen

Table 1. Details of rodenticide and calibrated dosages of anti-inflammatory drugs evaluated in poultry sheds.
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Brodifacoum—Both the sexes succumbed 100% to
brodifacoum wax cakes in both choice and no choice tests as
well as 24 and 48 hours exposure. Death occurred faster in
no choice test i.e., 4.6 days and 3.5 days in 24 and 48 hrs
exposure respectively, whereas in choice tests death occurred
in 6.7 and 6.1 days for 24 and 48 hrs exposed rats respectively. Comparatively lower amount of poison was ingested
during choice test: i.e., 3.31 mg/kg (24 hrs) and 4.39 mg/kg
(48 hrs) than during no choice test i.e., 6.5 mg/kg and 7.98
mg/kg for 24 and 48 hrs poisoned rats respectively
Experiments on oral toxicity established LD50 value of
brodifacoum as 0.9 mg/kg for male rats with confidence
limits of 0.276-2.923 mg/kg and for females 0.7 mg/kg with
confidence limits of 0.165-2.975 mg/kg.

Table 2. Field Trials of anticoagulants potentiated by ibuprofen
and phenylbutazone.

Tolerance limits of R.rattus to
ibuprofen and phenylbutazone
Ibuprofen—Rats treated with ibuprofen at 20 mg/kg,
40 mg/kg, 60 mg/kg and 80 mg/kg did not die even after 72
hrs but those which ingested 100 mg/kg died within 24 hrs
suggesting the tolerance limit to be 80 mg/kg.
Phenylbutazone at 100 mg/kg, 150 mg/kg and 200 mg/
kg induced 100 percent mortality after 24, 2 and half an
hour respectively. Therefore 50 mg/kg of phenylbutazone
seems to be the tolerance limit for R.rattus.

and phenylbutazone was arrived at by applying Duncan's
Multiple Range test (Fedrer 1963).
RESULTS
Toxicity of bromadiolone and brodifacoum
Bromadiolone—In no choice test, 24 hrs exposure of
bromadiolone cake (0.005%) resulted in mean 70% mortality
of R. rattus with females significantly ingesting more of wax
cake than males and succumbing 80% as compared to 60%
mortality of males. Forty eight hrs exposure to the poison
resulted in 90% mortality in males. Females ingested more
poison and succumbed 100%. Days to death was an average
of 7.9 days for 24 hrs poisoned rats and 5.78 days for 48 hrs
fed rats.
In choice tests only 60% of both sexes died in 7.8 days
when bromadiolone cake was fed for 24 hrs. Forty eight
hours exposure to the same resulted in 100 percent mortality
in 6.7 days.
Oral toxicity experiments demonstrated LD50 value of bromadiolone as 2.2 mg/kg with a confidence limit of 1.1-4.4 mg/
kg for males and 1.75 mg/kg for females with confidence
limits of 0.76-4.02 mg/kg.
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Potentiation of anticoagulant
activity of wax cakes by the two drugs
Bromadiolone—Rats fed with 80 mg/kg ibuprofen followed by exposure to bromadiolone wax cake for 24 hours
succumb within 24 hours compared to 100% mortality and
6.7 days to death when only bromadiolone cake was given
that too for 48 hrs. Even the amount of poison ingested,
2.52 mg/kg in choice test and 2.49 mg/kg in no choice test,
was less when compared to rats fed only on bromadiolone
(6.13 mg/kg),
Subcutaneous injection of phenylbutazone at 50 mg/kg
to bromadiolone poisoned rats also resulted in 100% overnight mortality in both no choice and choice tests compared
to 6.7 days when rats were exposed for 48 hrs to
bromadiolone cakes. Even the poison ingested was only 1.25
mg/kg in choice test and 1.73 mg/kg in no choice test (Table 3).
Brodifacoum — The potentiation of brodifacoum wax
cakes by the two NSAIDs was similar to that of bromadiolone. Ibuprofen + brodifacoum wax cake fed rats succumbed 100% overnight (Table 4) compared to 4.6 and 3.5
days taken by rats fed only on brodifacoum cakes for 24 and
48 hrs respectively in no choice tests and 6.7 and 6.1 days
taken by rats tested in choice tests after 24 and 48 hrs exposure. The poison ingested was similarly far less in ibuprofen
treated rats in choice test and no choice test compared to rats
poisoned with only brodifacum cake.
Phenylbutazone too potentiated the action of brodifacoum wax cakes by inducing death overnight and at concentrations far below that of rats exposed only to cakes both
in no choice and choice tests (Table 4).
Duncan's Multiple Range test (Fedrer 1963) revealed
following significant differences between bromodiolone
cake and brodifacoum cake poisoned rats and those rats
whose poison action was potentiated by ibuprofen and
phenylbutazone: (1) Between bromadiolone and brodifacoum, the later was more potent as seen by lesser amounts

Table 3. Evaluation of potentiation of bromadiolone cake by ibuprofen and phenylbutazone.

Table 4. Evaluation of potentiation of brodifacoum cakes by ibuprofen and phenylbutazone.

of bait requirement and shorter duration to death in both 24
and 48 hrs exposure to poison. (2) Both ibuprofen and
phenylbutazone potentiated the action of bromadiolone and
brodifacoum cakes. (3) The potentiation by phenylbutazone
was higher than that of ibuprofen. (4) The potentiation of
brodifacoum cakes by phenylbutazone was higher than that
of bromadiolone cakes (Table 5).
Potentiation of technical grade
anticoagulants by the two drugs
When rats were fed on sub-lethal doses of bromadiolone
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(2 mg/kg) and brodifacoum (1 mg/kg) by stomach intubation
and potentiated with ibuprofen and phenylbutazone, death
occured in comparatively shorter duration in ibuprofen treated
rats but overnight in phenylbutazone injected subjects (Table 6).
Duncan's Multiple Range test of experiments on potentiation of technical grade bromadiolone and brodifacoum by
ibuprofen and phenylbutazone indicated three significant
points: (1) That the two drugs significantly potentiated the
action of the two anticoagulants. (2) Between the two drugs,
phenylbutazone was more potent as seen by overnight mortality. (3) Brodifacoum was potentiated more than

Table 5. Duncan's analysis of the efficacy and potentiation of bromadiolone and brodifacoum cakes by NSAIDs in Rattus rattus.

bromadiolone as seen by shorter duration to death (Table 7).
Field evaluation of potentiated anticoagulants
Brodifacoum cake potentiated with ibuprofen and
phenylbutazone gave higher reduction of poultry shed rats
than similarly potentiated bromadiolone (Table 2) and between the two NSAIDs, phenylbutazone was more effective.
The same trend was seen when NSAIDs were added to poultry feed and exposed to rats along with the rodenticides (Table
2). Thus the field trials when subjected to Duncan's Multiple
Range test proved laboratory findings (Table 2).
DISCUSSION
With reports of development of resistance to brodifacoum and difenacoum (Rowe et al. 1981) it becomes imperative to evolve methods to overcome this problem. One
such approach could be to potentiate the second generation
anticoagulants by employing additives which can act as absorbers of vitamin K, capable of damaging capillaries, inducing injuries and interfering with the mechanism of clotting.
Activated clay, charcoal and carbon when combined with
warfarin resulted in 88%, 75% and 63% mortality which was
attributed to vitamin K absorption (Muktha Bai and Rao
1979). Similarly L-hystidine combined with low dosages of
warfarin caused 100% mortality of R.rattus due to haemorrhage caused by warfarin coupled with vasoconstrictor action
and release of natural heparin from liver by L-hystidine
(Muktha Bai and Rao 1979). The two non-steroidal anti-inflammatory drugs, phenylbutazone and ibuprofen potentiated
the action of bromadiolone and brodifacoum in the present
study by reducing time to death to overnight and reducing the
lethal doses. The NSAIDs are known to interact with oral
anticoagulants by a variety of mechanisms. Evidence is available to show that anticoagulants are affected by drugs which
alter their absorption, protein binding or metabolism
(Breckenbridge et al. 1978). Phenylbutazone displaces warfarin from albumin and invariably leads to increased
hypothrombinemia of anticoagulated patients (Koch-Weser
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Table 6. Potentiation of technical grade bromadiolone and
brodifacoum by ibuprofen and phenylbutazone.

Table 7. Duncan's analysis of potentiation of orally intubated bromadiolone and brodifacoum by anti-inflammatory drugs—
ibuprofen and phenylbutazone.

and Sellers 1971). It is also known to displace both warfarin
isomers from plasma albumin in vivo and in vitro. In humans
it is known to inhibit the biotransformation of the S isomer
while stimulating the elimination of R isomer. Since the S
isomer is 5 times more potent than R isomer, potentiation of
warfarin induced hypothrombinemia is reported to occur
(Sellers 1978).
A second way of potentiation of anticoagulants by
NSAIDs seems to be due to injuries caused. Many NSAIDs
including ibuprofen and phenylbutazone cause gastrointestinal damage by way of ulceration and bleeding (Van
kolfschoten et al. 1983). Of the two drugs phenylbutazone
was more potent ulcerogenic than ibuprofen (Diamentis et al.
1980). The present observations of shorter duration to death
at comparitively lower doses of anticoagulants when rats are
fed/injected with ibuprofen and phenylbutazone supplements
the findings of Diamentis et al. (1980).
The third way in which NSAIDs potentiate anticoagulants may be by affecting wound healing. Healing of wounds
has many phases such as granulation, collagenation, contraction, epithelization and scar remodelling. All these phases
excepting the last are dependent on each other and occur
simultaneously. Many NSAIDs are known to interfere with
one event or other. Diwan and Kulkarni (1986) observed
ibuprofen and phenylbutazone depressing granulation,
collagenation and initial phase of contraction of wounds.
It may be concluded that both ibuprofen and phenylbutazone enhance the efficacy of bromadiolone and
brodifacoum by affecting their binding, inducing gastric ulceration, bleeding and finally by interfering with natural
healing of wounds.
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